These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9260214)

  • 1. Measles vaccine in egg allergic children: poor immunogenicity of the Edmoston-Zagreb strain.
    Bruno G; Grandolfo M; Lucenti P; Novello F; Ridolfi B; Businco L
    Pediatr Allergy Immunol; 1997 Feb; 8(1):17-20. PubMed ID: 9260214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines.
    Schwarzer S; Reibel S; Lang AB; Struck MM; Finkel B; Gerike E; Tischer A; Gassner M; Glück R; Stück B; Cryz SJ
    Vaccine; 1998; 16(2-3):298-304. PubMed ID: 9607046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
    Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Albrecht P; Sever JL; Shekarchi I
    JAMA; 1984 May; 251(18):2363-71. PubMed ID: 6368888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
    JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.
    Low N; Kraemer S; Schneider M; Restrepo AM
    Vaccine; 2008 Jan; 26(3):383-98. PubMed ID: 18082295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infants.
    Tsai HY; Huang LM; Shih YT; Chen JM; Jiang TM; Tsai CH; Lee CY
    Viral Immunol; 1999; 12(4):343-8. PubMed ID: 10630793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of measles-mumps-rubella vaccine (MMR) in patients allergic to eggs.
    Cerecedo Carballo I; Dieguez Pastor MC; Bartolomé Zavala B; Sánchez Cano M; de la Hoz Caballer B
    Allergol Immunopathol (Madr); 2007; 35(3):105-9. PubMed ID: 17594874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
    Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
    Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines.
    Sakaguchi M; Nakayama T; Inouye S
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1058-61. PubMed ID: 8977505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allergic reactions to measles, mumps and rubella vaccine in children with egg protein allergy].
    Kornbrot B; Levy Y; Garty BZ; Danon YL
    Harefuah; 1990 Oct; 119(7-8):230-1. PubMed ID: 2258103
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
    Pool V; Braun MM; Kelso JM; Mootrey G; Chen RT; Yunginger JW; Jacobson RM; Gargiullo PM;
    Pediatrics; 2002 Dec; 110(6):e71. PubMed ID: 12456938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe administration of the measles vaccine to children allergic to eggs.
    James JM; Burks AW; Roberson PK; Sampson HA
    N Engl J Med; 1995 May; 332(19):1262-6. PubMed ID: 7708070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.